RO7568282

DRUG2 trials

Sponsors

Hoffmann-La Roche

Conditions

Alzheimer's DiseaseParkinson's Disease

Phase 1

Study to Test Effects and Safety of RO7568282 in Early Parkinson's Disease

Not yet recruitingNCT07781644

Hoffmann-La RocheParkinson's Disease

Start: 2026-09-30End: 2032-04-15Target: 474Updated: 2026-08-24

Phase 2

Study to Test Effects and Safety of RO7568282 in Early Symptomatic Alzheimer's Disease

Not yet recruitingNCT07781657

Hoffmann-La RocheAlzheimer's Disease

Start: 2026-10-31End: 2029-11-01Target: 450Updated: 2026-08-24